Assessment of network module identification across complex diseases

Abstract

Many bioinformatics methods have been proposed for reducing the complexity of large gene or protein networks into relevant subnetworks or modules. Yet, how such methods compare to each other in terms of their ability to identify disease-relevant modules in different types of network remains poorly understood. We launched the ‘Disease Module Identification DREAM Challenge’, an open competition to comprehensively assess module identification methods across diverse protein–protein interaction, signaling, gene co-expression, homology and cancer-gene networks. Predicted network modules were tested for association with complex traits and diseases using a unique collection of 180 genome-wide association studies. Our robust assessment of 75 module identification methods reveals top-performing algorithms, which recover complementary trait-associated modules. We find that most of these modules correspond to core disease-relevant pathways, which often comprise therapeutic targets. This community challenge establishes biologically interpretable benchmarks, tools and guidelines for molecular network analysis to study human disease biology. In this DREAM challenge, 75 methods for the identification of disease-relevant modules from molecular networks are compared and validated with GWAS data. The authors provide practical guidelines for users and establish benchmarks for network analysis.

Keywords

MeSH Terms

Affiliated Institutions

• Tufts University US
• Massachusetts General Hospital US
• SIB Swiss Institute of Bioinformatics CH
• Harvard University US
• Northeastern University US
• Broad Institute US
• Icahn School of Medicine at Mount Sinai US
• Heidelberg University DE
• University of Lausanne CH
• Roche (Switzerland) CH

Related Publications